Anti-Human CD336 Rabbit Recombinant Antibody

CD336 Uni-rAbTM Recombinant Antibody for FC
Cat No. 98371-1-RR

产品说明书

CloneNo. 242228B9

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC

NCR2, LY95, Lymphocyte antigen 95 homolog, Natural killer cell p44-related protein, NK cell activating receptor

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格价格库存


经过测试的应用

Positive FC detected inTransfected HEK-293T cells

推荐稀释比

应用推荐稀释比
Flow Cytometry (FC)FC : 0.25 ug per 10^6 cells in 100 μl suspension
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

98371-1-RR targets CD336 in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 Recombinant protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 natural cytotoxicity triggering receptor 2
别名 NCR2, LY95, Lymphocyte antigen 95 homolog, Natural killer cell p44-related protein, NK cell activating receptor
计算分子量31 kDa
GenBank蛋白编号NM_004828
基因名称 CD336
Gene ID (NCBI) 9436
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein A purification
UNIPROT IDO95944
储存缓冲液 PBS with 0.09% sodium azide, pH 7.3.
储存条件Store at 2 - 8°C. Stable for one year after shipment.

背景介绍

CD336, also named as NCR2, LY95 and NKp44, belongs to the natural cytotoxicity receptor (NCR) family. It is cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis. It is expressed on activated human NK cells. CD336 displays a single extracellular Ig-like V domain and a transmembrane portion containing the charged residue (Lysine), likely involved in the association with KARAP/DAP12 molecules. The antibody is specific to CD336.

实验方案

Product Specific Protocols
FC protocol for CD336 antibody 98371-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...